Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10923-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10923-1-AP, RRID:AB_2097096
- Product name
- E2F4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated E2F4 antibody (Cat. #10923-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase.
Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation.
Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression.
Stable overexpression of p130/E2F4 affects the multipotential abilities of bone-marrow-derived mesenchymal stem cells.
Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.
Wang Y, Lu H, Sun L, Chen X, Wei H, Suo C, Feng J, Yuan M, Shen S, Jia W, Wang Y, Zhang H, Li Z, Zhong X, Gao P
Cell death & disease 2021 Oct 2;12(10):902
Cell death & disease 2021 Oct 2;12(10):902
Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation.
Huang W, Hu H, Zhang Q, Wu X, Wei F, Yang F, Gan L, Wang N, Yang X, Guo AY
Oncogene 2019 Oct;38(42):6818-6834
Oncogene 2019 Oct;38(42):6818-6834
Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression.
Sutton MN, Huang GY, Zhou J, Mao W, Langley R, Lu Z, Bast RC Jr
Cancers 2019 Apr 30;11(5)
Cancers 2019 Apr 30;11(5)
Stable overexpression of p130/E2F4 affects the multipotential abilities of bone-marrow-derived mesenchymal stem cells.
Zhang X, Chen J, Liu A, Xu X, Xue M, Xu J, Yang Y, Qiu H, Guo F
Journal of cellular physiology 2018 Dec;233(12):9739-9749
Journal of cellular physiology 2018 Dec;233(12):9739-9749
Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.
Valle BL, D'Souza T, Becker KG, Wood WH 3rd, Zhang Y, Wersto RP, Morin PJ
PloS one 2013;8(4):e61836
PloS one 2013;8(4):e61836
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- A431 cells were subjected to SDS PAGE followed by western blot with 10923-1-AP(E2F4 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The E2F4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human E2F4. This antibody recognizes human, mouse, rat antigen. The E2F4 antibody has been validated for the following applications: ELISA, WB, IHC analysis.